Researchers found that people are more willing to take risks when confident in their knowledge and less likely to do so when unsure. This discovery has significant implications for various decision-making processes.
Simon C. Moss, a UH professor, has spent 40 years researching atomic-scale defects and their impact on materials properties. His work has led to breakthroughs in semiconductors, alloys, and thin films, earning him the Von Hippel Award.
Researchers at Johns Hopkins have developed a potential new screening test for prostate cancer by measuring the level of GSTP1 methylation in tissue samples. High levels of methylation were detected in 91.3% of early-stage cancers and 53.6% of precancerous lesions, suggesting its potential as an early diagnostic marker.
A new Stanford University study analyzed the costs and benefits of two treatments: implantable cardioverter defibrillators (ICDs) and the drug amiodarone. ICDs were found to be the most effective in preventing sudden cardiac death, but also came with the highest costs. Amiodarone produced intermediate benefits and costs.
A survey of over 400 doctors found that nearly a third would assist with lethal injections, highlighting the need for education on ethical guidelines and professional obligations. The study's authors warn that physicians' personal opinions on capital punishment may not align with their professional duties.
A team from Arizona State University has questioned the evidence for bacterial life in a Martian meteorite, citing limitations in microscope technology and data selection. The researchers argue that the shapes of magnetite crystals found in the meteorite are not uniquely identifiable with bacteria.
Researchers identified a mutated WFS1 gene responsible for low-frequency sensorineural hearing loss, which can lead to severe hearing aids requirements. The discovery may be common in the general population and could connect with other conditions like Meniere's Disease.
A new pilot study aims to investigate whether treating periodontal disease can reduce the risk of heart attacks. The three-year study will follow approximately 900 patients who have had a heart attack or are at high risk of one, comparing those who receive aggressive treatment for gum disease with those who do not.